Table 5.

Descriptive statistics and regression results of the comparison of healthcare facilities by TB/HIV integration level, adjusted for age, gender, intervention effects and change in guidelines, and clustering by healthcare facility

	TB/HIV Integration Status		Regression Results
	Total	Not integrated	Integrated	OR (95% CI)	p-value	Adjusted OR (95% CI)	p-value
ART Indicator+
Proportion of TB/HIV patients started on ART	38.5% (67/174)	33.8% (24/71)	47.7% (43/103)	1.40 (0.33, 6.02)	0.648	1.34 (0.40, 4.47)	0.632
TB Indicators++
Proportion of TB/HIV patients with treatment success (completed or cured)	54.5% (126/231)	53.8% (49/91)	55.0% (77/140)	1.05 (0.47, 2.35)	0.910	1.43 (0.73, 2.82)	0.298
Proportion of TB/HIV patients who died during TB treatment	19.5% (45/231)	27.5% (25/91)	14.3% (20/140)	0.44* (0.26, 0.73)	0.002	0.38* (0.18, 0.77)	0.008
Proportion of TB/HIV patients who were lost to follow-up during TB treatment+++	24.7% (57/231)	17.6% (16/91)	29.2% (41/140)	1.94 (0.52, 7.30)	0.326	1.64 (0.53, 5.04)	0.386
Proportion of TB/HIV patients who had TB treatment failure+++	1.3% (3/231)	1.10% (1/91)	1.4% (2/140)	1.30 (0.18, 9.58)	0.794	1.21 (0.34, 4.32)	0.774

^*p<0.01

⁺Of the 296 in the sample, 122 (41.2%) were not included in the analysis: 84 (68.9%) were already on ART prior to starting TB treatment, and thus were not eligible, 38 (31.1%) were missing ART start date and were excluded because it was unclear whether they started ART before or after TB treatment. Those missing comprised 18 (20.2%) of the non-integrated time period and 20 (16.3%) of the integrated time period samples.

⁺⁺Of the 296 in the sample, 65 (22.0%) had outcomes missing - 26 (22.2%) of the non-integrated time period and 39 (22.2%) of the integrated time periods samples.

⁺⁺⁺Age was omitted in the final model for lost to follow-up due to collinearity. Age and time period were omitted in the model for TB treatment failure, due to collinearity.